BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18836892)

  • 1. Decreased body mass index as an independent risk factor for developing chronic kidney disease.
    Tokashiki K; Tozawa M; Iseki C; Kohagura K; Kinjo K; Takishita S; Iseki K
    Clin Exp Nephrol; 2009 Feb; 13(1):55-60. PubMed ID: 18836892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003).
    Iseki K; Kohagura K; Sakima A; Iseki C; Kinjo K; Ikemiya Y; Takishita S
    Hypertens Res; 2007 Jan; 30(1):55-62. PubMed ID: 17460372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease.
    Iseki K; Tokashiki K; Iseki C; Kohagura K; Kinjo K; Takishita S
    Clin Exp Nephrol; 2008 Oct; 12(5):363-369. PubMed ID: 18584288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD).
    Iseki K; Tohyama K; Matsumoto T; Nakamura H
    Hypertens Res; 2008 Feb; 31(2):249-55. PubMed ID: 18360044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives.
    Satirapoj B; Supasyndh O; Mayteedol N; Punpanich D; Chaiprasert A; Nata N; Ruangkanchanasetr P; Kanjanakul I; Choovichian P
    Nephrology (Carlton); 2013 Mar; 18(3):229-34. PubMed ID: 23279639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and chronic kidney disease in Okinawa, Japan.
    Tanaka H; Shiohira Y; Uezu Y; Higa A; Iseki K
    Kidney Int; 2006 Jan; 69(2):369-74. PubMed ID: 16408128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa.
    Iseki K; Horio M; Imai E; Matsuo S; Yamagata K
    Clin Exp Nephrol; 2009 Feb; 13(1):44-9. PubMed ID: 18854923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the body mass index and chronic kidney disease in men and women. A population-based study from Israel.
    Cohen E; Fraser A; Goldberg E; Milo G; Garty M; Krause I
    Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv130-5. PubMed ID: 24179008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between body mass index and CKD in apparently healthy men.
    Gelber RP; Kurth T; Kausz AT; Manson JE; Buring JE; Levey AS; Gaziano JM
    Am J Kidney Dis; 2005 Nov; 46(5):871-80. PubMed ID: 16253727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults.
    Noori N; Hosseinpanah F; Nasiri AA; Azizi F
    J Ren Nutr; 2009 May; 19(3):228-37. PubMed ID: 19261489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
    Chen J; Gu D; Chen CS; Wu X; Hamm LL; Muntner P; Batuman V; Lee CH; Whelton PK; He J
    Nephrol Dial Transplant; 2007 Apr; 22(4):1100-6. PubMed ID: 17272313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.
    Foster MC; Hwang SJ; Larson MG; Lichtman JH; Parikh NI; Vasan RS; Levy D; Fox CS
    Am J Kidney Dis; 2008 Jul; 52(1):39-48. PubMed ID: 18440684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?
    Hallan S; de Mutsert R; Carlsen S; Dekker FW; Aasarød K; Holmen J
    Am J Kidney Dis; 2006 Mar; 47(3):396-405. PubMed ID: 16490617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes.
    Ogna A; Forni Ogna V; Bochud M; Guessous I; Paccaud F; Burnier M; Wuerzner G
    Eur J Nutr; 2016 Apr; 55(3):1089-97. PubMed ID: 25971845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and the risk of development of end-stage renal disease in a screened cohort.
    Iseki K; Ikemiya Y; Kinjo K; Inoue T; Iseki C; Takishita S
    Kidney Int; 2004 May; 65(5):1870-6. PubMed ID: 15086929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.